{"id":"https://openalex.org/W2093100880","doi":"https://doi.org/10.1158/1538-7445.am2011-5032","title":"Abstract 5032: Targeting Src in mucinous ovarian carcinoma","display_name":"Abstract 5032: Targeting Src in mucinous ovarian carcinoma","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2093100880","doi":"https://doi.org/10.1158/1538-7445.am2011-5032","mag":"2093100880"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-5032","doi":"https://doi.org/10.1158/1538-7445.am2011-5032","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-5032","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000713007","display_name":"Koji Matsuo","orcid":"https://orcid.org/0000-0002-6232-8701","observed_orcids":["https://orcid.org/0000-0002-6232-8701"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koji Matsuo","raw_affiliation_strings":["1University of Southern California, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Southern California, Los Angeles, CA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967062","display_name":"Masato Nishimura","orcid":"https://orcid.org/0000-0003-4540-6402","observed_orcids":["https://orcid.org/0000-0003-4540-6402"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masato Nishimura","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108410080","display_name":"Rebbeca L. Stone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebbeca L. Stone","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061302509","display_name":"Kakajan Komurov","orcid":"https://orcid.org/0000-0003-4834-9845","observed_orcids":["https://orcid.org/0000-0003-4834-9845"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kakajan Komurov","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022224126","display_name":"Mian M.K. Shahzad","orcid":"https://orcid.org/0000-0002-3462-0377","observed_orcids":["https://orcid.org/0000-0002-3462-0377"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mian MK Shahzad","raw_affiliation_strings":["3University of Wisconsin, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Wisconsin, Madison, WI","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015034565","display_name":"Justin N. Bottsford-Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin N. Bottsford-Miller","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056238856","display_name":"Takayuki Enomoto","orcid":"https://orcid.org/0000-0003-4538-5541","observed_orcids":["https://orcid.org/0000-0003-4538-5541"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takayuki Enomoto","raw_affiliation_strings":["4Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101777383","display_name":"Tadashi Kimura","orcid":"https://orcid.org/0000-0002-4391-6866","observed_orcids":["https://orcid.org/0000-0002-4391-6866"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadashi Kimura","raw_affiliation_strings":["4Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016846753","display_name":"Prahlad T. Ram","orcid":"https://orcid.org/0000-0003-4739-3166","observed_orcids":["https://orcid.org/0000-0003-4739-3166"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prahlad T. Ram","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079236834","display_name":"Kathleen M. Schmeler","orcid":"https://orcid.org/0000-0002-9670-4189","observed_orcids":["https://orcid.org/0000-0002-9670-4189"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen M. Schmeler","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082358197","display_name":"Michael Frumovitz","orcid":"https://orcid.org/0000-0002-0810-2648","observed_orcids":["https://orcid.org/0000-0002-0810-2648"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Frumovitz","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111690153","display_name":"Gary E. Gallick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary G. Gallick","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018745283","display_name":"Kwong\u2010Kwok Wong","orcid":"https://orcid.org/0000-0002-0375-6669","observed_orcids":["https://orcid.org/0000-0002-0375-6669"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kwong K. Wong","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100640276","display_name":"Anil K. Sood","orcid":"https://orcid.org/0000-0002-5415-9901","observed_orcids":["https://orcid.org/0000-0002-5415-9901"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil K. Sood","raw_affiliation_strings":["2UT MD-Anderson Cancer Center, Houston, TX","2UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT MD-Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"2UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"5032","last_page":"5032"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10364","display_name":"Reproductive Biology and Fertility","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mucinous-ovarian-carcinoma","display_name":"mucinous ovarian carcinoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/src-kinase","display_name":"Src kinase","score":0.8029999732971191},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.753000020980835},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.3970000147819519},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.6449999809265137},{"id":"https://openalex.org/keywords/serous-ovarian-cancer","display_name":"serous ovarian cancer","score":0.6140000224113464},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.7170000076293945},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.531000018119812},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6499999761581421},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5920000076293945},{"id":"https://openalex.org/keywords/stage-at-diagnosis","display_name":"stage at diagnosis","score":0.3880000114440918},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.46799999475479126},{"id":"https://openalex.org/keywords/signaling-pathways","display_name":"signaling pathways","score":0.6499999761581421},{"id":"https://openalex.org/keywords/synergistic-antitumor-effect","display_name":"synergistic antitumor effect","score":0.6110000014305115},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.34599998593330383},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.8168675899505615},{"id":"https://openalex.org/C2777874381","wikidata":"https://www.wikidata.org/wiki/Q6931137","display_name":"Mucinous carcinoma","level":4,"score":0.6692681312561035},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.6506374478340149},{"id":"https://openalex.org/C2777632260","wikidata":"https://www.wikidata.org/wiki/Q19000698","display_name":"Serous carcinoma","level":4,"score":0.6033518314361572},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.5620234608650208},{"id":"https://openalex.org/C2781199814","wikidata":"https://www.wikidata.org/wiki/Q18556242","display_name":"Clear cell carcinoma","level":3,"score":0.5515496730804443},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5498183965682983},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5169074535369873},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48350289463996887},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.47965410351753235},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46600326895713806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4641624093055725},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.43566423654556274},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.41610926389694214},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.24254697561264038},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.12735092639923096},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07595044374465942}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-5032","doi":"https://doi.org/10.1158/1538-7445.am2011-5032","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-5032","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8100000023841858,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2418809770","https://openalex.org/W2079051762","https://openalex.org/W2525874609","https://openalex.org/W2399128414","https://openalex.org/W2494600548","https://openalex.org/W2256515710","https://openalex.org/W4353029051","https://openalex.org/W2737333160","https://openalex.org/W2140049927","https://openalex.org/W2942673563"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"Mucinous":[2],"ovarian":[3,15,25,44,48,78,86,103,122,157,165,189,196,309,338],"carcinomas":[4,26,57],"have":[5],"a":[6,28,99,177,182],"distinct":[7,162],"clinical":[8,21,334],"pattern":[9],"compared":[10,82,128],"to":[11,72,129,315],"other":[12],"subtypes":[13],"of":[14,23,36,42,55,92,155,184,210,223,227,247,305,323,348,353],"carcinomas.":[16],"We":[17],"evaluated":[18,59],"(i)":[19],"stage-specific":[20],"significance":[22],"mucinous":[24,43,56,77,102,121,156,195,308,337],"in":[27,39,98,180,251,273,277,284,336],"large":[29],"cohort":[30],"and":[31,142,213,262,272,291,325],"(ii)":[32],"the":[33,193,200,278,349,354],"functional":[34,68],"role":[35],"src":[37,66,93,112,173,202,211,319],"kinase":[38,94,113,174,203,212,320],"pre-clinical":[40],"models":[41],"carcinoma.":[45,339],"METHODS:":[46],"1302":[47],"cancer":[49,79,87,104,123,158,166,190,197],"patients":[50],"including":[51],"122":[52],"(9.4%)":[53],"cases":[54],"were":[58,70,96,161,218],"for":[60,75,332,357],"survival":[61,127,144,304],"analyses.":[62],"Gene":[63,153],"microarrays":[64],"with":[65,83,117,131,220,229,307,313,321],"specific":[67],"analysis":[69],"performed":[71],"identify":[73],"biomarkers":[74],"2":[76],"cell":[80,88,159,167,191,238],"lines":[81,160],"5":[84],"serous":[85,132,164],"lines.":[89,168],"Biological":[90],"effects":[91,235,276],"inhibition":[95],"tested":[97],"novel":[100],"orthotopic":[101],"model":[105,280],"(RMUG-S-ip2)":[106],"using":[107],"dasatinib-based":[108],"therapy,":[109],"an":[110,329],"oral":[111],"inhibitor.":[114],"RESULTS:":[115],"Patients":[116],"advanced-stage":[118],"(stage":[119],"III/IV)":[120],"had":[124],"significantly":[125],"worse":[126],"those":[130],"histology:":[133],"median":[134,143],"overall":[135],"survival,":[136],"1.67":[137],"versus":[138,149,287,292],"3.41":[139],"years,":[140,151],"p=0.002;":[141],"time":[145],"after":[146],"recurrence,":[147],"0.53":[148],"1.66":[150],"p<0.0001.":[152],"expressions":[154],"from":[163],"Pathway":[169],"analyses":[170],"showed":[171,199],"that":[172,302],"might":[175],"be":[176,328],"key":[178],"factor":[179],"regulating":[181],"number":[183],"signaling":[185],"pathways.":[186],"Among":[187],"10":[188],"lines,":[192],"RMUG-S-ip2":[194,279],"cells":[198,250],"highest":[201],"activity.":[204],"Moreover,":[205],"oxaliplatin":[206,228,258,261,288,326],"treatment":[207],"induced":[208,216],"phosphorylation":[209],"Akt.":[214],"These":[215],"activities":[217],"inhibited":[219],"concurrent":[221],"administration":[222],"dasatinib.":[224],"Combination":[225],"therapy":[226],"dasatinib":[230,255,293,324],"further":[231,333],"demonstrated":[232],"significant":[233],"synergistic":[234],"on":[236],"reducing":[237],"viability":[239],"(interaction":[240],"index":[241],"<1),":[242],"increasing":[243],"apoptosis":[244],"(mean":[245],"percentage":[246],"total":[248],"apoptotic":[249],"RUMG-S-ip2,":[252],"untreated":[253],"vs":[254,257,260,265,267,269],"alone":[256,259],"dasatinib,":[263],"4.1%":[264],"8.5%":[266],"9.5%":[268],"26.8%,":[270],"p<0.01),":[271],"vivo":[274],"anti-tumor":[275],"(tumor":[281],"reduction":[282],"rate":[283],"combination":[285,322],"therapy:":[286],"monotherapy":[289,294],"79.1%,":[290],"74.7%,":[295],"both":[296],"p<0.01).":[297],"CONCLUSION:":[298],"Our":[299],"results":[300],"suggest":[301],"poor":[303],"women":[306],"carcinoma":[310],"is":[311],"associated":[312],"resistance":[314],"cytotoxic":[316],"therapy.":[317],"Targeting":[318],"may":[327],"attractive":[330],"approach":[331],"development":[335],"Citation":[340],"Format:":[341],"{Authors}.":[342],"{Abstract":[343],"title}":[344],"[abstract].":[345],"In:":[346],"Proceedings":[347],"102nd":[350],"Annual":[351],"Meeting":[352],"American":[355],"Association":[356],"Cancer":[358,368],"Research;":[359],"2011":[360],"Apr":[361],"2-6;":[362],"Orlando,":[363],"FL.":[364],"Philadelphia":[365],"(PA):":[366],"AACR;":[367],"Res":[369],"2011;71(8":[370],"Suppl):Abstract":[371],"nr":[372],"5032.":[373],"doi:10.1158/1538-7445.AM2011-5032":[374]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}